Connective tissue diseases (CTDs) such as systemic lupus erythematosus, systemic
sclerosis, myositis, Sjögren's syndrome, and rheumatoid arthritis are systemic diseases …

The discovery of autoantibodies to ribosomal proteins (anti-RibP) dates back more than fifty
years when antibodies to ribosomes were identified in systemic lupus erythematosus (SLE) …

In 18 of 20 patients with psychosis secondary to systemic lupus erythematosus (SLE),
autoantibodies to ribosomal P proteins were detected by immunoblotting and measured with …

For centuries, lupus erythematosus was felt to be only a chronic skin condition. In 1872,
however, Moriz Kaposi emphasized the systemic nature of this disease. One of the visceral …

Abstract purpose: The goal of this study was to determine whether elevated serum levels of
antibodies to ribosomal P proteins (anti-P antibodies) are associated with neuropsychiatric …

Autoimmune diseases currently affect 5–7% of the world's population; in most diseases
there are circulating autoantibodies. Brain-reactive antibodies are present in approximately …

OBJECTIVE: We sought (1) to identify and (2) to define the association of all reported
antibodies (Abs) with neuropsychiatric lupus (NPSLE),(3) to search for possible mechanisms …

Objective. To examine cognitive and psychological functioning in relation to antiribosomal P
protein autoantibodies in patients with systemic lupus erythematosus (SLE) who had no …

Neuropsychiatric (NP) manifestations are found in approximately 25% of children and
adolescents with pediatric SLE (pSLE). In 70% of those, NP involvement will occur within the …

Neuropsychiatric systemic lupus erythematosus (NPSLE) is one of the most important
manifestations of SLE, and includes a variety of clinical manifestations, classified by the …